Axinn Expands IP and Regulatory Practice with Partner Aziz Burgy
December 16, 2015
Axinn is pleased to announce that Aziz Burgy has joined the firm as a partner in the IP Group. Mr. Burgy, who will be based in Axinn’s Washington, DC office, previously practiced as a partner at Arent Fox LLP.
"We are excited to have Aziz,” said Managing Partner James Veltrop. “He is a highly-regarded attorney who understands the need to harmonize litigation, regulatory, and business strategies. His skills in handling complex matters and his deep knowledge of the life sciences industry perfectly complement the areas in which our firm has become a recognized leader."
Mr. Burgy has over a dozen years of patent litigation experience, including over 30 pharmaceutical and medical device cases. He also has extensive experience litigating before the U.S. Patent & Trademark Office. Mr. Burgy has tried other types of patent cases in U.S. district courts and before the International Trade Commission, including those involving medical devices, Internet security, robotics, software, and GPS technology.
Mr. Burgy earned his J.D. at the University of New Hampshire School of Law and holds a Master of Biotechnology from Johns Hopkins University. Prior to attending law school, he worked at MedImmune, Inc.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
Informa 35th Annual Advanced EU London Conference
Speaking Engagement
Antitrust
AHLA Health Care Transactions Program 2026
Sponsorship
Antitrust
Conspiracy Theories Newsletter, 2026 Edition
Byline Articles
Antitrust
Axinn Partners John Harkrider and Craig Minerva Win 2026 Concurrences Antitrust Writing Award
Awards & Recognitions
Antitrust
Axinn Wins Firm of the Year – Americas at 2026 Global Competition Review Awards
Awards & Recognitions
Antitrust
IPWatchdog Sixth Annual Live Conference
Speaking Engagement
Intellectual Property
Is Any Deal Safe From Review in the EU? Implications of the “Towercast” Judgment
Podcast
Antitrust
Axinn Antitrust Insight: HSR Overhaul: Out with the New, In with the Old
Axinn Viewpoints
Antitrust
The DOJ's Whistleblower Program and Leniency
Axinn Viewpoints
Antitrust
Squires Again Broadens Discretion for Post-Grant Proceedings
Axinn Viewpoints
Intellectual Property
